Battling Chronic Heart Failure: Deploying Special Forces
March 6, 2018
March 6, 2019
Scroll to the Bottom of this Information to Begin this Course
This activity is provided by Paradigm Medical Communications, LLC.
This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.
- Physicians — maximum of 0.5 AMA PRA Category 1 Credit™
- Pharmacists — 0.5 hours (0.05 CEUs).
All other health care professionals completing this course will be issued a statement of participation.
This activity has been designed to address the educational needs of cardiologists, internists, and pharmacists. This activity may also be of benefit to other healthcare providers interested in optimal management of heart failure.
Upon completion of this activity, participants should be able to:
- Describe the clinical evidence for, and appropriate use of, newer chronic heart failure therapies.
- Outline treatment strategies to reduce hospitalizations and readmissions for patients with chronic heart failure in accordance with current guideline recommendations.
Table of Contents
- Safety and Efficacy of Next Generation Chronic HF Therapies
- Panel Discussion
Akshay Suvas Desai, MD, MPH (Chair)
Heart Failure Disease Management Program
Brigham and Women’s Hospital
Associate Professor of Medicine
Harvard Medical School
Kirkwood F. Adams, Jr., MD
Associate Professor of Medicine and Radiology
Division of Cardiology
University of North Carolina at Chapel Hill
Chapel Hill, NC
J. Bradley Williams, PharmD, BCPS
Heart Failure/Heart Transplant Clinical Pharmacy Specialist
Department of Pharmacy
Physician Accreditation Statement
Paradigm Medical Communications, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Physician Credit Designation Statement
Paradigm Medical Communications, LLC designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacist Accreditation and Designation Statement
Educational Review Systems is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This program is approved for 0.5 hours (0.05 CEUs) of continuing pharmacy education credit. Proof of participation will be posted to your NABP CPE profile within 4 to 6 weeks to participants who have successfully completed the post-test. Participants must participate in the entire presentation and complete the course evaluation to receive continuing pharmacy education credit. (Universal Activity Number 0761-9999-17-321-H01-P)
This is a knowledge-based activity.
This activity is jointly provided by Educational Review Systems, Inc. and Paradigm Medical Communications, LLC.
Disclosures of Conflicts of Interest
In accordance with ACCME and ACPE requirements on disclosure, faculty and contributors are asked to disclose any relationships with commercial interests associated with the area of medicine featured in the activity. These relationships are described below.
Akshay Suvas Desai, MD, MPH (Chair)
- Grant/Research Support: Novartis Pharmaceuticals Corporation
- Retained Consultant/Speaker: Abbott; AstraZeneca; DalCor Pharmaceuticals; Novartis Pharmaceuticals Corporation; Relypsa Inc.
Kirkwood F. Adams, Jr., MD
- Grant/Research Support: Amgen, Inc.; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Otsuka America Pharmaceutical, Inc.; Roche Diagnostics
- Retained Consultant: Novartis Pharmaceuticals Corporation; Roche Diagnostics.
J. Bradley Williams, PharmD, BCPS
- No financial relationships to disclose.
Paradigm Medical Communications, LLC staff members have no financial relationships to disclose.
Educational Review Systems, Inc. staff members have no financial relationships to disclose.
Independent peer reviewer has no financial relationships to disclose.
Resolution of Conflict of Interest
Paradigm Medical Communications, LLC and Educational Review Systems, Inc. have implemented a system to resolve conflicts of interest for each CME/CPE activity to help ensure content objectivity, independence, fair balance, and that the content is aligned with the interest of the public. Conflicts, if any, are resolved through one or more processes. All CME/CPE content in this activity was independently reviewed to ensure that it is free of commercial bias, scientifically rigorous, aligned with the public interest, and compliant with all regulatory guidance and the ACPE Guidelines and ACCME’s Standards for Commercial Support of Continuing Medical Education.
Instructions for Participation
To receive CME/CPE credit, you should:
- Follow the "Start Activity" button to go to the Paradigm Medical Communications website, where you will complete the pretest.
- View the online activity in its entirety.
- Complete and submit the online posttest and evaluation. You must answer 70% of the posttest questions correctly to earn credit. You will have unlimited opportunities to successfully complete the posttest.
A certificate of participation/statement of completion will be available for download/printing immediately following your successful completion of the posttest and evaluation. Your certificate/statement will be saved on the Paradigm Medical Communications website and will not be available in your freeCME CME History.
Please note: to claim CPE credit, please make sure you include your date of birth and NABP number. All credit information will be uploaded into CPE Monitor within 30 days.
For questions regarding CME/CPE credit, contact the Paradigm CME Department at (845) 398-5949.
There is no fee required for participation in this activity.
Hardware and Software Requirements
This certified CME/CPE activity is designed using HTML5 video.
For Desktops (Windows/Mac)
Internet Explorer 9 or higher, Firefox 28 or higher, Safari 5.1 or higher, Google Chrome 31 or higher, Opera 21 or higher
For Tablets (iPad/android/Surface)
iOS Safari 4 or higher, android 2.3 or higher, IE Mobile 10 or higher
Technical Support: If you have any technical problems or playback issues, email us at firstname.lastname@example.org.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA.
This CME/CPE activity represents the views and opinions of the individual faculty, and does not constitute the opinion or endorsement of, or promotion by, Paradigm Medical Communications, LLC or Educational Review Systems, Inc. Reasonable efforts have been taken to present educational subject matter in a balanced, unbiased fashion, and in compliance with regulatory requirements. However, each activity participant must always use his or her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.
If included, signed statements of informed consent granting permission for publication have been obtained for all photographs and videos in which an individual can be identified.
As an ACCME-accredited provider, Paradigm Medical Communications, LLC activities must include a balanced view of therapeutic options. Use of generic names contributes to this impartiality. The use of trade names should not be viewed as an endorsement of specific products by Paradigm Medical Communications, LLC.
The materials provided for this activity are for informational purposes only, and should not be used for diagnosis or treatment of a health problem without consulting a licensed medical professional. Any views or opinions presented are solely those of the Faculty, and do not necessarily represent those of Paradigm Medical Communications, LLC or Educational Review Systems, Inc. References to any entity, product, service, or source of information on this website should not be considered an endorsement, either direct or implied, by Paradigm Medical Communications, LLC or Educational Review Systems, Inc. Paradigm Medical Communications, LLC and Educational Review Systems, Inc accept no liability for the content referenced in this activity.
Paradigm Medical Communications, LLC and Educational Review Systems, Inc. are committed to protecting the privacy of those who participate in the activities (herein referred to as “website") located at www.paradigmmc.com. The information below describes the security of the website for safeguarding personal information and the rationale for collection and use of personal information.
Security/Safeguarding Personal Information
This website has physical and procedural safeguards in place to prevent unauthorized access to personal information used to access this website.
Collection and Use of your Personal Information
The submission of certain personally identifiable information is necessary to award and track the credits participants may earn after completing the program. Required items include first name, last name, degree, and email address. These items are necessary. Participants are also required to complete an evaluation of the CME/CPE activity. All evaluative information submitted is collected and retained, and used by Paradigm Medical Communications, LLC and Educational Review Systems, Inc.to continuously improve the learning experience.
Paradigm Medical Communications, LLC and Educational Review Systems, Inc do not transfer, sell, or share personal information with outside parties. Paradigm Medical Communications, LLC and Educational Review Systems, Inc. will not otherwise disclose personal information unless required to in a legal process. Paradigm Medical Communications, LLC, and Educational Review Systems, Inc. staff members review individual test results to the extent necessary to record and track participants’ credits.
If you have any questions or comments, please email us at email@example.com.
© 2018 Paradigm Medical Communications, LLC, except where noted. Content may not be reproduced in whole or part without the express written permission of Paradigm Medical Communications, LLC.